Rising Prevalence Of Vision Disorders Driving Growth In The Implantable Collamer Lens Market Driving Market Acceleration in the Implantable Collamer Lens Industry, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Implantable Collamer Lens Market Size By 2025?
In recent years, the implantable collamer lens market has seen significant growth. The market size is predicted to expand from $19.53 billion in 2024 to $20.77 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.3%. The surge in growth during the historical period is largely due to the rising awareness about vision correction alternatives, increased adoption of less invasive surgical procedures, escalating prevalence of refractive errors, beneficial reimbursement policies in critical regions, and greater investment in eye-related research.

How Big Is the Implantable Collamer Lens Market Size Expected to Grow by 2029?
Expectations are high for substantial growth in the implantable collamer lens market in the coming years. The market is anticipated to expand to a value of $27 billion by 2029, showcasing a compound annual growth rate (CAGR) of 6.8%. This growth within the forecast period can be linked to the escalating demand for permanent vision correction options, the increasing prevalence of vision conditions such as myopia and astigmatism, a heightened focus on personalized and patient-specific implants, the growing needs for eye care in our aging population, and the proliferation of outpatient surgical centers. Key trends projected within the forecast period encompass the integration of AI in the pre-surgical planning phase, the invention of foldable and biocompatible lens materials, partnerships between manufacturers and healthcare providers, breakthroughs in lens materials and style innovations, along with progression in implantable lens technology.

View the full report here:
https://www.thebusinessresearchcompany.com/report/implantable-collamer-lens-global-market-report

Which Key Market Drivers Powering Implantable Collamer Lens Market Expansion and Growth?
The implantable collamer lens market is anticipated to grow due to the escalating presence of visual impairment disorders. These disorders, which progressively erode visual acuity and eye health, affect individuals' capacity to see clearly. Factors such as an aged populace, increased interaction with screens, and the rising incidence of complications like myopia and age-related macular degeneration explain the global surge in vision impairments. As an alternative to traditional refractive surgeries like LASIK, Implantable Collamer Lenses (ICLs) serve as a secure, reversible remedy for rectifying vision disorders like myopia, hyperopia, and astigmatism. For instance, a World Health Organization report from August 2023 indicated that worldwide, over 2.2 billion individuals struggle with near or distant visual impairment, and 1 billion of these instances could have been prevented or are still unmanaged. In addition, in July 2023, the Welsh Government reported that the number of new certificates of vision impairment (CVI) issued in 2021-22 stood at an estimated 1,563, marking a 49.1% increase from the preceding year. Consequently, the mounting incidence of eye disorders is propelling growth in the implantable collamer lens market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20840&type=smp

What Are the Key Trends Driving Implantable Collamer Lens Market Growth?
Leading businesses in the implantable collamer lens (ICL) industry are positioning themselves competitively by concentrating on technological advancements in lenses and securing necessary approvals. The ICL, specifically intended to correct refractive vision anomalies, provides a less invasive treatment for myopia and astigmatism. In a recent development in April 2022, STAAR Surgical Company, an American firm specialising in the production and marketing of implantable lenses and associated delivery mechanisms for the eye, divulged that the EVO/EVO+ Visian Implantable Collamer Lens (EVO) has received approval from the U.S. Food and Drug Administration (FDA) for treating myopia and myopia associated astigmatism. The EVO Visian ICL lens is engineered to correct or lessen nearsightedness within -3.0 D to -20.0 D, and manage astigmatism varying from 1.0 D to 4.0 D.

What Are the Emerging Segments in the Implantable Collamer Lens Market?
The implantable collamer lens market covered in this report is segmented -

1) By Type: Visian Implantable Collamer Lens (ICL), EVO Implantable Collamer Lens (ICL)
2) By Technology Adoption: Laser-Assisted Techniques, Traditional Techniques
3) By Application: Myopia, Hyperopia, Astigmatism
4) By End User: Ophthalmic Clinics, Hospitals, Ambulatory Surgical Center, Other End User

Subsegments:
1) By Visian Implantable Collamer Lens (ICL): Visian ICL for Myopia, Visian ICL For Hyperopia, Visian ICL For Astigmatism, Visian ICL For Presbyopia
2) By EVO Implantable Collamer Lens (ICL): EVO ICL For Myopia, EVO ICL For Hyperopia, EVO ICL For Astigmatism, EVO ICL For Presbyopia

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=20840&type=smp

Who Are the Global Leaders in the Implantable Collamer Lens Market?
Major companies operating in the implantable collamer lens market are STAAR Surgical Company

Which are the Top Profitable Regional Markets for the Implantable Collamer Lens Industry?
North America was the largest region in the implantable collamer lens market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable collamer lens market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20840

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.